Evidence map›Paper›PMID 41850821›Full record

ArticleMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine2026

Histopathological Basis of Peritumoral Enhancement in Muscle-invasive Bladder Cancer.

Hiroyuki Watanabe, Mitsuru Takeuchi, Atsushi Higaki, Yuichi Kojima, Takuma Maruhisa, Akira Yamamoto, Takuya Moriya, Tsutomu Tamada

Abstract read
In one paragraph

Article in Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Role of MRI in the Clinical Management of Urologic and Nephrological Disorders.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hiroyuki WatanabeDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0009-0006-0855-0658
Mitsuru TakeuchiDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0000-0002-3005-8487
Atsushi HigakiDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0000-0003-4857-4372
Yuichi KojimaDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0009-0000-4193-2427
Takuma MaruhisaDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Akira YamamotoDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0000-0001-7220-3446
Takuya MoriyaDepartment of Pathology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Tsutomu TamadaDepartment of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan.ORCID http://orcid.org/0000-0003-2521-9570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePeritumoral enhancement (PTE) on dynamic contrast-enhanced MRI is a highly specific imaging feature of muscle-invasive bladder cancer (MIBC). However, the histopathological basis of PTE remains unclear. This study aimed to elucidate the pathological substrates underlying PTE, by correlating MRI findings with quantitative histopathological analysis.

methodsThis retrospective cross-sectional study included 14 patients with pathologically confirmed MIBC who underwent preoperative multiparametric MRI followed by radical cystectomy. PTE was assessed on preoperative dynamic contrast-enhanced MRI by 4 experienced radiologists, and its thickness was measured. Postoperatively, histopathological evaluation was performed in 3 regions: intratumoral area (ITA), peritumoral area (PTA), and non-tumoral muscularis propria (MP). Fibrosis was quantified using Masson trichrome staining, T-lymphocytes using CD8 immunohistochemistry, and microvessels using CD31 immunostaining. Quantitative spot-based analysis and continuous ROI-based spatial analysis were performed along the invasive front of the tumor. Regional comparisons were conducted using the Wilcoxon signed-rank test with Bonferroni correction.

resultsPTE thickness on MRI ranged from 1 to 2 mm (median, 1.5 mm), spatially corresponding to the histologically defined PTA. The fibrosis area fraction was significantly higher in the PTA than the ITA and MP (all P < 0.001), with continuous spatial analysis demonstrating a distinct peak immediately outside the tumor invasive margin. T-lymphocyte counts and area fractions were significantly higher in both the ITA and PTA than in the MP, with no significant differences between the ITA and PTA. The number of microvessels was significantly higher in the PTA than in the MP, but did not differ significantly between the PTA and ITA. Microvessel density was significantly higher in the PTA than in both the ITA and MP.

conclusionPTE reflects localized stromal remodeling at the tumor invasive front, characterized predominantly by marked peritumoral fibrosis accompanied by increased microvessel density.

Indexed as

Magnetic Resonance ImagingUrinary Bladder NeoplasmsAgedContrast MediaCross-Sectional StudiesCystectomyDynamic Contrast Enhanced Magnetic Resonance ImagingFemaleFibrosisHumansMaleMiddle AgedNeoplasm InvasivenessRetrospective StudiesUrinary BladderContrast Mediabladder cancerfibrosismagnetic resonance imagingpathologyperitumoral enhancement

Identifiers

PMID41850821
PMCPMC13547776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.